MODERN VIEW ON THE PROBLEM OF ANTIBIOTIC RESISTANCE IN PULMONOLOGY AND PHTHISIATRY (LITERATURE REVIEW)

Author:

Pylypiv Lesya1ORCID,Piskur Zoriana2ORCID

Affiliation:

1. Department of Internal Medicine №2, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine

2. Department of Phthisiology and Pulmonology, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine

Abstract

Introduction. The problem of antibiotic resistance (AR) is threatening for patients with respiratory tract diseases (RTD). The use of antibiotics in the treatment of pneumonia, which can be prescribed in the schemes for the tuberculosis (TB) treatment, creates the prerequisites for the formation of chemoresistance of mycobacterium tuberculosis (MBT). The purpose of our research is to analyze the scientific literature on the causes and factors of the occurrence of AR of the сommon RTD pathogens (pneumonia, tuberculosis). Materials and methods. The information on AR of pneumonia and tuberculosis causative agents obtained from scientific publications published in the «pubmed» and «scopus» databases has been analyzed. Results. The main factors causing AR in European countries today are: low awareness of the public and medical professionals about AR, over-the-counter purchase of antibiotics, use of antibiotic residues, the desire of doctors to avoid complications of the disease, advertising of pharmaceutical products, frequent lack of diagnostic tests to detect common infections. The vast majority of antibiotic prescriptions in ambulatory practice are for the treatment of respiratory tract infections, but up to 90% of them are unwarranted. Сoncomitant diseases of the patient (chronic kidney disease, bronchopulmonary diseases, liver diseases), previous colonization of the oropharynx with AR pathogens, bedridden state, age up to 2 years can be risk factors for AR of pneumonia pathogens. The physician should be alert for M. tuberculosis infection and perform appropriate diagnosis in patients with suspected pneumonia, especially in children, the elderly, and patients with HIV and comorbidities. It has been established that less than 65 years of age, living in a large family, history of TB treatment, contact with TB patients, history of hospitalization and visits to medical institutions, TB/HIV co‑infection, bad habits (smoking, alcohol consumption), glycosylated hemoglobin level ˃ 7% were risk factors for chemoresistant TB in adults. Risk factors for chemoresistant extrapulmonary TB in children were: up to 1 year of age, living in a village, poor family income, contact with bacterial isolates of resistant MBT strains, lack of BCG vaccination, concomitant pathology. Conclusions. In order to reduce the prevalence of AR of the RTD pathogens, clear algorithms for prescribing antibiotics should be developed, patients should be trained in their correct use, and methods of diagnosing common infections should be improved. In order to overcome CR TB, it is necessary to detect patients in time and block the transmission of infection, develop clear control algorithms for the detection and treatment of CR TB in risk groups, for example, among patients with diabetes, intensify the development of drugs with new mechanisms of action, initiate testing for the detection of TB in risk groups with suspected pneumonia.

Publisher

Sumy State University

Reference35 articles.

1. WHO Regional Office for Europe/European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2022 – 2020 data. Copenhagen: WHO Regional Office for Europe; 2022.

2. O’Neill J. Tackling drug-resistant infections globally: Final report and recommendations. The review on antimicrobial resistance. 2016.

3. Nandi A, Pecetta S, Bloom DE. Global antibiotic use during the COVID-19 pandemic: analysis of pharmaceutical sales data from 71 countries, 2020-2022. EClinicalMedicine. 2023 Mar;57:101848. https://doi.org/10.1016/j.eclinm.2023.101848. Epub 2023 Feb 6. PMID: 36776504; PMCID: PMC9900305.

4. World health organization. The top 10 causes of death.

5. Centers for Disease Control and Prevention. 2019 Antibiotic Resistance Threats Report [Internet].

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3